Prostate Cancer Genetic Risk Evaluation and Screening Study

Clinical trial NCT05129605 · RECRUITING

Trial details

NCT number: NCT05129605
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Prostatic Neoplasm Prostate Cancer BRCA2 Mutation BRCA1 Mutation ATM Gene Mutation MMR Mutation Lynch Syndrome Genetic Predisposition to Disease

Start date: 2020-02-12
Primary completion: 2030-12-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.